- Home
- MFIN vs TVGN Comparison
MFIN vs TVGN Comparison
Compare MFIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- TVGN
- Stock Information
- Founded
- MFIN 1995
- TVGN 2020
- Country
- MFIN United States
- TVGN United States
- Employees
- MFIN N/A
- TVGN N/A
- Industry
- MFIN Finance: Consumer Services
- TVGN Blank Checks
- Sector
- MFIN Finance
- TVGN Finance
- Exchange
- MFIN Nasdaq
- TVGN Nasdaq
- Market Cap
- MFIN 243.9M
- TVGN 179.0M
- IPO Year
- MFIN 1996
- TVGN N/A
- Fundamental
- Price
- MFIN $10.44
- TVGN $0.86
- Analyst Decision
- MFIN Strong Buy
- TVGN Strong Buy
- Analyst Count
- MFIN 1
- TVGN 1
- Target Price
- MFIN $12.00
- TVGN $10.00
- AVG Volume (30 Days)
- MFIN 35.3K
- TVGN 484.0K
- Earning Date
- MFIN 10-28-2025
- TVGN 08-14-2025
- Dividend Yield
- MFIN 4.58%
- TVGN N/A
- EPS Growth
- MFIN N/A
- TVGN N/A
- EPS
- MFIN 1.75
- TVGN N/A
- Revenue
- MFIN $332,256,000.00
- TVGN N/A
- Revenue This Year
- MFIN N/A
- TVGN N/A
- Revenue Next Year
- MFIN $1.53
- TVGN N/A
- P/E Ratio
- MFIN $5.98
- TVGN N/A
- Revenue Growth
- MFIN 16.48
- TVGN N/A
- 52 Week Low
- MFIN $7.52
- TVGN $0.26
- 52 Week High
- MFIN $10.98
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- MFIN 50.26
- TVGN 37.96
- Support Level
- MFIN $10.33
- TVGN $0.84
- Resistance Level
- MFIN $10.64
- TVGN $0.87
- Average True Range (ATR)
- MFIN 0.21
- TVGN 0.04
- MACD
- MFIN -0.05
- TVGN 0.00
- Stochastic Oscillator
- MFIN 28.33
- TVGN 10.27
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.